The Great Directory Rollup: How H1 Is Building the Single Source of Truth for Provider Networks
Dr. Dereck Mush, MD, MBA
Biolevate
Evidence-grade AI supporting scientific and regulatory workflows in life sciences.
What they do
Biolevate provides an AI platform for regulated life-sciences work, including evidence synthesis and co-authoring clinical protocols and clinical study reports. The company is based in Paris and announced a Boston office in 2026. Its verified offering is evidence-based workflow support, not a general clinical-trial simulation engine.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Regulated life sciences workflows
- Product type
- Platform software
- Stage
- Not disclosed
- Headquarters
- Paris, France
- Region
- Europe
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
The $2.4B Oral Macrocycle and Bispecific Surge: Why Big Pharma Is Buying Platform Engines Over Single Assets
Dr. Dereck Mush, MD, MBA
Beyond Gluten Avoidance: How argenx's CD122 Blockade Advances Pharmacological Protection in Celiac Disease
Dr. Dereck Mush, MD, MBA
The Oral Endocrine Pivot: Inside Sling Therapeutics' $123M Bet on Linsitinib
Dr. Dereck Mush, MD, MBA